Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: A mechanistic study

AAPS PharmSciTech

Volumn 10, Issue 1, 2009, Pages 199-210

  Sapra, Bharti ^a   Jain, Subheet ^a   Tiwary, Ashok K ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Asparagus racemosus; Biochemical estimation; Carvedilol; Chitosan; Differential scanning calorimetry; Saponin; Scanning electron microscopy; Transmission electron microscopy

Indexed keywords

ASPARAGUS RACEMOSUS EXTRACT; CARVEDILOL; CHITOSAN; CHOLESTEROL; DEOXYCORTICOSTERONE ACETATE; SPHINGOSINE; TRIACYLGLYCEROL; ANTIHYPERTENSIVE AGENT; CARBAZOLE DERIVATIVE; DEOXYCORTICOSTERONE; PLANT EXTRACT; PROPANOLAMINE DERIVATIVE; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; EPIDERMIS; HYPERTENSION; IN VITRO STUDY; MALE; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; TRANSDERMAL PATCH; TRANSMISSION ELECTRON MICROSCOPY; WATER LOSS; WISTAR RAT; ANIMAL; ASPARAGUS; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG EFFECT; FEMALE; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHARMACEUTICS; PLANT ROOT; SKIN ABSORPTION; TIME;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ASPARAGUS PLANT; BLOOD PRESSURE; CARBAZOLES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; EPIDERMIS; FEMALE; HYPERTENSION; MALE; PERMEABILITY; PLANT EXTRACTS; PLANT ROOTS; PROPANOLAMINES; RATS; RATS, WISTAR; SAPONINS; SKIN ABSORPTION; SPHINGOSINE; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; TRIGLYCERIDES;

EID: 67549147386     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9198-1     Document Type: Article

References (41)

1. B. W. Barry. Breaching the skin's barrier to drugs. Nat. Biotechnol. 22:165-167 (2004).
2. W. S. Pray. Nonprescription Product Therapeutics, Lippincott Williams & Wilkins, Philadelphia, 2003.
3. M. Goodman, and B. W. Barry. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:323-327 (1988).
4. W. Meier, and U. Hoppe. Texture analysis of the surface of human skin. Skin Pharmacol. 8: 252-256 (1995).
5. J. L. Zatz. Skin Permeation Fundamentals and Applications, Allured Pub. Co., Carol Stream, IL, USA, 1993.
6. V. P. Shah. Skin penetration enhancers: Scientific perspective. In D. S. Hsieh (ed.), Drug Permeation and Enhancement, Marcel Dekker, New York, USA, 1994, pp. 19-23.
7. A. Nokhodchi, J. Shokri, A. Dashbolaghi, D. Hassan-Zadeh, T. Ghafourian, and M. Barzegar-Jalali. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm. 250:359-369 (2003).
8. K. Babita, V. Rana, and A. K. Tiwary. Lipid synthesis inhibitors: Effect on epidermal lipid conformational changes and percutaneous permeation of Levodopa. AAPS PharmSciTech. 6:E473-E481 (2005).
9. K. Babita, and A. K. Tiwary. Transcutaneous delivery of levodopa: enhancement by fatty acid synthesis inhibition. Mol. Pharm. 2:57-63 (2005).
10. K. Davar. Drug-surfactant interactions: Effect on transport properties. Int. J. Pharm. 155:179-190 (1997).
11. S. Choi, S. Y. Jung, C. H. Kim, H. S. Kim, H. Rhim, S. C. Kim, and S. Y. Nah. Effect of Ginsenosides on voltage-dependent Ca2+ channel subtypes in bovine chromaffin cells. J. Ethnopharmacol. 74: 75-81 (2001).
12. L. Menin, M. Panchichkina, C. Keriel, J. Olivares, U. Braun, E. K. Seppert, and V. A. Saks. Macrocompartmentation of total creatine in cardiomyocytes revisited. Mol. Cell. Biochem. 220:149-159 (2001).
13. A. Plock, W. Sokolowska-Kohler, and W. Presber. Application of flow cytometry and microscopical methods to characterize the effect of herbal drugs on Leishmania spp. Exp. Parasitol. 97:141-153 (2001).
14. P. Seeman. Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed. Proc. 33:2116-2124 (1974).
15. P. Seeman, D. Cheng, and G. H. Iles. Structure of membrane holes in osmotic and saponin hemolysis. J. Cell Biol. 56:519-527 (1973).
16. K. Brain, J. Hadgraft, and M. Al-Shatalebi. Membrane modification in activity of plant molluscicides. Planta Med. 56:663 (1990).
17. N. G. M. Schipper, S. Olsson, J. A. Hoogstraate, A. G. deBoer, K. M. Varum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 14: 923-929 (1997).
18. J. Smith, E. Wood, and M. Dornish. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21:43-49 (2004).
19. M. Goodman, and B. W. Barry. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:323-327 (1988).
20. T. Morgan. Clinical pharamacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet. 26:335-346 (1994).
21. A. M. Kligman, and E. Christophers. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88:702-705 (1963).
22. J. Folch, M. Lees, and G. H. Sloane-Stanley. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226:497-502 (1957).
23. R. Sabbadini, W. M. McNutt, G. Jenkins, R. Betto, and G. Salviati. Sphingosine is endogenous to cardiac and skeletal muscle. Biochem. Biophys. Res. Commun. 3:752-758 (1993).
24. S. Singh, M. Bi, S. B. Jayaswal, and J. Singh. Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis. Int. J. Pharm. 166:157-166 (1998).
25. B. A. I. Van den Bergh, D. C. Swartzendruber, A. B. Geest, J. J. Hoogstraate, A. H. G. J. Schrijvers, H. E. Bodde, H. E. Junginger, and J. A. Bouwstra. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J. Microsc. 187: 125-133 (1997).
26. V. Rogiers. TEWL-measurements in patch test assessment: The need for standardisation. Current problems in dermatology. In P. Elsner, and H. I. Maibach (eds.), Irritant Dermatitis, New Clinical and Experimental Aspects, Karger, Basel, 1995, pp. 152-158.
27. M. Khazaei, and M. Nematbakhsh. The effect of hypertension on serum nitric oxide and vascular endothelial growth factor concentrations. A study in DOCA-salt hypertensive overiectomized rats. Regulatory Pept. 135:91-94 (2006).
28. J. Shokri, A. Nokhodchi, A. Dashbolaghi, D. Hassan- Zadeh, T. Ghafourian, and M. B. Jalali. The effect of surfactants on the skin permeation of diazepam. Int. J. Pharm. 228:99-107 (2001).
29. M. Gibaldi, and S. Feldman. Mechanisms of surfactant effects on drug absorption. J. Pharm. Sci. 59:579-589 (1970).
30. A. Nokhodchi, H. Nazemiyeh, T. Ghafourian, D. Hassan-Zadeh, H. Valizadeh, and L. A. S. Bahary. The effect of glycyrrhizin on the release rate and skin penetration of diclofenac sodium from topical formulations. Il Farmaco. 57: 883-888 (2002).
31. B. Sapra, S. Jain, and A. K. Tiwary. Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation. Drug Deliv. 15:443-454 (2008).
32. G. M. Golden, D. B. Guzek, R. R. Harris, J. E. McKie, and R. O. Potts. Lipid thermotropic transitions in human stratum corneum. J. Invest. Dermatol. 86:255-259 (1986).
33. K. Knutson, R. O. Potts, D. B. Guzek, G. M. Golden, J. E. Mckie, W. J. Lambert, and W. I. Higuchi. Macro and molecular physical chemical considerations in understanding drug transport in the stratum corneum. J. Control. Release. 2:67-87 (1985).
34. B. F. Van Duzee. Thermal analysis of human stratum corneum. J. Invest. Dermatol. 65:404-408 (1975).
35. H. K. Vaddi, P. C. Ho, Y. W. Chan, and S. Y. Chan. Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum. Biol. Pharm. Bull. 26:220-228 (2003).
36. N. Yamashita, K. Tachibana, K. Ogawa, N. Tsujita, and A. Tomita. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat. Rec. 247:455-461 (1997).
37. J. A. Bouwstra, K. Cheng, G. S. Gooris, A. Weerheim, and M. Ponec. The role of ceramides 1 and 2 in the stratum corneum lipid organization. Biochim. Biophys. Acta. 1300:177-186 (1996).
38. R. M. Lavker. Membrane-coating granules: The fate of the discharged lamellae. J. Ultrastruct. Res. 55:79-86 (1979).
39. M. A. Lampe, M. L. Williams, and P. M. Elias. Human epidermal lipid characterization and modulation during differentiation. J. Lipid Res. 24:131-140(1983).
40. M. Fujimaki, H. Hakusui, Y. Hasegawa, H. Ajima, H. Ota, S. Igafashi, and H. Yamamura. Pharmacokinetics of carvedilol (DQ-2466) in healthy subjects. Jpn. J. Clin. Pharmacol. Ther. 21:415-424 (1990).
41. N. Hokama, N. Hobra, H. Kameya, S. Ohshiro, and M. Sakanashi. Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J. Chromatogr. B. 732:233-238 (1999).